Illumina, Inc.
NASDAQ:ILMNMedical - Diagnostics & Research
+$1.95 today
- Market cap
- $31.75B
- Beta
- 1.49
- P/E (TTM)
- 28.9
- EPS (TTM)
- $5.58
Volume 1.63M
Average 1.65M
ILMN Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Illumina, Inc.NASDAQ: ILMN
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables declines year over year
Q2 FY2026 accounts payables of $12M fell 20.0% year over year, ahead of the -54.1% change in trailing-twelve-month accounts payables.
Context
- Accounts payables amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -20.0% holds above the trailing-twelve-month pace of -54.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 2M USD
- Year-over-year change
- +150.0%
- 4-year CAGR
- -57.3%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-28 | 2M | +150.0% |
| FY2024 | 2024-12-29 | (4M) | +90.9% |
| FY2023 | 2023-12-31 | (44M) | -15.8% |
| FY2022 | 2023-01-01 | (38M) | -163.3% |
| FY2021 | 2022-01-02 | 60M | — |
Accounts Payables vs competitors
How ILMN compares with its peers on the latest reported figures
- ILMN's LTM Jun 2026 accounts payables of $28M is the 3rd largest of the 11 companies compared; the peer median is $2.89M.
- Its year-over-year change of -54.1% is the 6th highest of 9, against a peer median of +189.9%.
- Accounts payables amounts to 0.6% of revenue for ILMN, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $41.71M | — | — | 3.3% | |
| LTM Jun 2026 | $29.39M | +734.8% | -48.3% | 1.1% | |
| LTM Jun 2026 | $28M | -54.1% | — | 0.6% | |
| LTM Jun 2026 | $16.49M | -289.5% | — | 2.2% | |
| LTM Mar 2026 | $12.45M | +595.4% | — | 15.3% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $5.65M | -882.7% | -29.5% | 1.2% |
| LTM Mar 2026 | $4M | +385.7% | -26.3% | 0.5% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $3.33M | — | — | 0.8% |
| LTM Jun 2026 | $2.46M | +144.1% | — | 0.4% | |
| LTM Mar 2026 | $1.73M | +235.6% | +13.8% | 2.7% | |
| LTM Mar 2026 | $315K | -95.3% | +34.3% | 0.2% | |
| Peer median (excluding ILMN) | $2.89M | +189.9% | -26.3% | 1.2% | |
Competitors are the stored peer set for ILMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 762M | (4.4B) | (1.16B) | (1.22B) | 850M |
| Depreciation & Amortization | 251M | 394M | 432M | 354M | 270M |
| Deferred Income Tax | (76M) | (23M) | (33M) | (112M) | 119M |
| Stock-Based Compensation | 754M | 366M | 380M | 370M | 275M |
| Change in Working Capital | (152M) | 204M | (90M) | (483M) | (153M) |
| Accounts Receivables | (164M) | (12M) | (40M) | (25M) | (108M) |
| Inventory | (58M) | (135M) | (20M) | 19M | (17M) |
| Accounts Payables | 60M | (38M) | (44M) | (4M) | 2M |
| Other Working Capital | 10M | 389M | 14M | (473M) | (30M) |
| Other Non-Cash Items | (994M) | 3.86B | 950M | 1.93B | (282M) |
| Operating Cash Flow | 545M | 392M | 478M | 837M | 1.08B |
| Capital Expenditures | (208M) | (286M) | (195M) | (128M) | (148M) |
| Acquisitions (Net) | (2.44B) | (265M) | (29M) | 2M | (10M) |
| Purchases of Investments | (77M) | (40M) | (6M) | (52M) | 0 |
| Sales of Investments | 1.66B | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | (1M) | 0 | 103M |
| Investing Cash Flow | (1.07B) | (591M) | (231M) | (178M) | (55M) |
| Debt Repayment | 471M | 991M | (1.24B) | 491M | (5M) |
| Common Stock Issued | 60M | 63M | 67M | 56M | 44M |
| Common Stock Repurchased | 0 | 0 | 0 | (116M) | (742M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (582M) | (54M) | (42M) | (1B) | (41M) |
| Financing Cash Flow | (51M) | 1B | (1.21B) | (570M) | (744M) |
| Effect of Forex Changes | (3M) | (22M) | 0 | (10M) | 11M |
| Net Change in Cash | (578M) | 779M | (963M) | 79M | 291M |
| Free Cash Flow | 337M | 106M | 282M | 709M | 931M |
Illumina, Inc.
NASDAQ:ILMN
Intrinsic Alpha fair value
Locked
Current Price
$210.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.